Penile Squamous Cell Carcinoma: Anatomic, Pathologic and Viral Studies in Paraguay (1993-2007) – Abstract
Monday, 22 October 2007
Pathology Department, Harvard Medical School, Boston, Massachusetts, USA.
efvelazquez@partners.org
read more
|
Beyond the Abstract - Mohs Micrographic Surgery for Penile Cancer: Management and Long-Term Followup
Friday, 19 October 2007
BERKELEY, CA (UroToday.com) - Although rare in the United States, penile cancer is a potentially lethal and psychologically devastating malignancy. Conventional treatment with partial or total penectomy is rejected by many patients leading to needless morbidity and mortality.
Login to read more...
|
Penile Cancer: an Overview - Abstract
Wednesday, 10 October 2007
UCLA Medical Center, Los Angeles, CA,. USA
read more
|
Mohs Micrographic Surgery for Penile Cancer: Management and Long-Term Followup - Abstract
Tuesday, 09 October 2007
Division of Urology, Department of Surgery (AWS, RYL, SBB)
read more
|
Demographic and Pathologic Differences in the Incidence of Invasive Penile Cancer in the United States, 1995-2003 - Abstract
Monday, 08 October 2007
Etiology Program, Cancer Research Center of Hawaii, University of Hawaii, 1236 Lauhala Street, Honolulu, HI 96813. marc@crch.hawaii.edu
read more
|
Reliability and Safety of Current Dynamic Sentinel Node Biopsy for Penile Carcinoma - Abstract
Friday, 05 October 2007
Department of Urology, The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
read more
|
A 10-Year Retrospective Audit of Penile Cancer Management in the UK - Abstract
Wednesday, 03 October 2007
Department of Urology, Unviersity Hospital Coventry and Warwickshire, Coventry, UK.
read more
|
Immunohistochemical Differentiation of High-Grade Prostate Carcinoma from Urothelial Carcinoma - Abstract
Monday, 01 October 2007
Department of Pathology, Koo Foundation Sun Yat-Sen Cancer Center, Taipei, Taiwan
read more
|
Preoperative Lymphoscintigraphy and Dynamic Sentinel Node Biopsy for Staging Penile Cancer: Results with Pathological Correlation
Wednesday, 30 May 2007
BERKELEY, CA (UroToday.com) - An inguinal lymph node dissection (ILND) for penile carcinoma is associated with surgical morbidity. A long-standing issue in the staging of this disease is whether a dynamic sentinel lymph node biopsy (DSNB) is adequate to avoid the ILND. Dr. Spiess and associates at MD Anderson Cancer Center and collaborating institutions reported on this topic in the June 2007 issue of the Journal of Urology.
read more
|
Video Endoscopic Inguinal Lymphadenectomy: A New Minimally Invasive Procedure for Radical Management of Inguinal Nodes in Patients With Penile Squamous Cell Carcinoma
Monday, 23 April 2007
BERKELEY, CA (UroToday.com) - The concept of video endoscopic inguinal lymphadenectomy (VEIL) was initially described by Bishoff and colleagues in studies they performed in cadavers.
read more
|
EAU 2007 - Debate - Plenary Session
Wednesday, 28 March 2007
read more
|
FDA Strengthens Safety Information for Erythropoiesis-Stimulating Agents (ESAs)
Wednesday, 14 March 2007
BERKELEY, CA (UroToday.com) - On March 9, 2007, the Food and Drug Administration issued a safety warning for all erythropoiesis-stimulating agents
read more
|
Nephrovesical Subcutaneous Ureteric Bypass: Long-term Results in Patients with Advanced Metastatic Disease—Improvement of Renal Function and Quality of Life
Monday, 22 January 2007
BERKELEY, CA (UroToday.com) - Managing extrinsic compression of the ureter by retrograde stenting is first-line therapy but involves a guarded decision because stent failure occurs in nearly half of treated patients.
read more
|
American Urological Association Names New Director of Guidelines
Wednesday, 03 January 2007
BALTIMORE, January 2007 — The American Urological Association (AUA) has announced that Heddy Hubbard, Ph.D., M.P.H., R.N., F.A.A.N. will be the new Director of Guidelines for the association. Dr. Hubbard joined the AUA on December 28, 2006.
read more
|
Report on 100 Cases of Penile Cancer Managed According to EAU Guidelines Suggests that Improvements Necessary
Wednesday, 20 September 2006
BERKELEY, CA (UroToday.com) - Squamous cell cancer (SCC) of the penis is a disease with a highly variable incidence worldwide. Incidences in the U.S and Great Britain are low (< 0.5% of all male malignancies), where the incidence can reach 10-20% in parts of South America, Asia and Africa.
read more
|
European Society for Urological Research to Host Congress in Malmo, Sweden
Friday, 08 September 2006
ARNHEM, THE NETHERLANDS (Press Release) - September 2006 - The European society for urological research (ESUR) will host its 17th congress in Malmö, Sweden from 14 to 16 September.
read more
|
Size of Metastasis in the Sentinel Node Predicts Additional Nodal Involvement in Penile Carcinoma
Thursday, 07 September 2006
BERKELEY, CA (UroToday.com) - Penile carcinoma has a strong tendency toward lymphatic dissemination and the inguinal lymph nodes are the first site of metastasis.
read more
|
Urologic Professionals to Learn Latest Practice Advances at Society of Urologic Nurses and Associates Annual Conference
Monday, 10 July 2006
Pitman, NJ - The Society of Urologic Nurses and Associates' (SUNA) will hold its 2006 Annual Conference in Kansas City, MO, October 27-30, 2006, at the Hyatt Regency Crown Center.
read more
|
AUA 2006 - EDG-PET CT Imaging Useful In Penile Cancer Staging
Monday, 22 May 2006
Abstract 601
Seitz and colleagues presented data from 17 patients with penile cancer who underwent PET CT imaging.
read more
|
Single-Dose Carboplatin Comparable To Prophylactic Radiotherapy For Stage I Seminoma: Results Of A Randomized Trial
Thursday, 13 April 2006
BERKELEY, CA (UroToday.com) - The risk of relapse for patients with stage I seminoma has traditionally ranged between 10 and 15%, depending on the local pathological characteristics of the tumor.
read more
|
Ask The ASCO Expert Events In March On PLWC
Friday, 03 February 2006
During the month of March, the American Society of Clinical Oncology's
(ASCO) patient information website, People Living With Cancer (www.plwc.org) will host two Ask the ASCO Expert events.
read more
|
Soft X-Ray Therapy Useful For Cutaneous Epithelial Malignancies
Wednesday, 04 January 2006
NEW YORK (Reuters Health) - Soft X-ray therapy of cutaneous basal and squamous cell carcinomas, using a radiation schedule that takes into account the clinically observed tumor involution under treatment, may be a good alternative to surgery for an increasing number of older patients with co-morbidities, according to a group of dermatologists from Germany.
read more
|
Review Discusses Advancements In The Treatment Of Carcinoma Of The Penis Over The Past Two Decades
Thursday, 08 December 2005
BERKELEY, CA (UroToday.com) - Carcinoma of the penis in the United States is a relatively uncommon malignancy, constituting < 1% of all malignancies in men.
read more
|
Penile Brachytherapy: Results for 49 Patients
Wednesday, 01 June 2005
BERKELEY, CA (UroToday Inc.) - While amputative surgery continues to be the standard of care for invasive penile carcinoma, in many countries radiotherapy is widely employed for local control with penile preservation.
read more
|
In Randomized Study of Patients with Localized Cancer and DVT, Low Molecular Weight Heparin found to offer Survival Advantage over Coumarin Derivatives
Friday, 15 April 2005
BERKELEY, CA (UroToday Inc.) - Without question, patients with cancer at a higher risk for thromboembolic events. Until very recently, the decision to place a patient with deep vein thrombosis (DVT) on coumarin or low molecular weight heparin was largely based on drug cost or patient convenience.
read more
|
Sentinel Lymph Node Biopsy in Penile Carcinoma has Low Morbidity, But a Significant False-Negative Rate
Tuesday, 22 March 2005
BERKELEY, CA (UroToday Inc.) - Penile squamous cell carcinoma (SCC) metastatic to the inguinal lymph nodes carries a poor outcome in the absence of surgical intervention.
read more
|
Analysis of UK Penile Cancer Registry Indicates Variations in Care
Tuesday, 21 December 2004
BERKELEY, CA (UroToday Inc.) - Penile cancer is an uncommon malignancy. On average, urologists in the UK see fewer than one new case per year.
read more
|
Elderly Patients Underrepresented in Trials of New Cancer Drugs
Wednesday, 17 November 2004
NEW YORK (Reuters Health) - New research indicates that cancer patients over 65 years of age are underrepresented in registration trials of new cancer agents.
read more
|
Large Review of Primary Female Urethral Carcinoma Outcomes Reinforces Aggressive Nature of the Disease
Friday, 12 November 2004
BERKELEY, CA (UroToday Inc.) - Primary carcinoma of the female urethra is uncommon, representing only 0.02% of all cancers found in women.
read more
|
Review of Squamous Cell Carcinoma of the Penis Cases from a Large Database Illustrates Aggressive Course of Disease
Friday, 29 October 2004
BERKELEY, CA (UroToday Inc.) - Squamous cell carcinoma of the penis is a relatively rare malignancy, accounting for only approximately 0.4-0.6% of all malignancies diagnosed among males in the U.S. and Europe.
read more
|
Whole Body MRI Rapidly Scans for Metastases
Thursday, 14 October 2004
NEW YORK (Reuters Health) - The results of whole body magnetic resonance imaging (MRI) compare well with other methods of evaluating metastases and can be done rapidly, German researchers report in the October issue of Radiology.
read more
|
Laser Treatment for Penile Carcinoma Leaves Erectile Function Intact
Wednesday, 15 September 2004
NEW YORK (Reuters Health) - Laser therapy is an effective treatment for localized penile carcinoma that does not affect erectile function in most men, according to the results of a small study published in the August issue of The Journal of Urology.
read more
|
Laser Treatment of Localized Penile Carcinoma Preserves the Penis, Provides Satisfactory Sexual Function and Cosmetic Results
Friday, 20 August 2004
BERKELEY, CA (UroToday Inc.) - The conventional treatment for carcinoma of the penis is partial or complete amputation of the penis.
read more
|
Physical Symptoms Predict Survival Time in Terminal Cancer
Tuesday, 27 July 2004
NEW YORK (Reuters Health) - Physical symptoms that affect health-related quality-of-life (QOL), such as nausea and dyspnea, appear to be associated with shorter survival in terminal cancer patients, researchers report in the July 26th online edition of Cancer.
read more
|
Modified Inguinal Lymphadenectomy for Invasive Penile Carcinoma Reduces Complication Rate
Thursday, 08 July 2004
BERKELEY, CA (UroToday Inc.) - Inguinal lymphadenectomy is commonly performed for treatment of metastases from penile carcinoma. This procedure has an essential role in the cure of patients.
read more
|
Quality of Life for Cancer Patients May Be All in the Genes
Thursday, 10 June 2004
NEW ORLEANS (Reuters Health) - The results of a new study provide preliminary evidence of a "potentially strong and specific" relationship between the genetic makeup of cancer patients and their quality of life (QOL) during cancer treatment.
read more
|
Cancer Trial Participants Rarely Told of Results
Wednesday, 21 April 2004
NEW YORK (Reuters Health) - Cancer patients who participate in clinical trials are often left in the dark about the results of the studies, according to a new report.
read more
|
New Tumor Classification Scheme Unlinks Tumor Type From Tumor Site
Wednesday, 24 March 2004
NEW YORK (Reuters Health) - A radically different new system for classification of tumors has been set forth by a National Cancer Institute official.
read more
|
Aprepitant Regimen Sustains Antiemetic Effect Over Multiple Chemotherapy Cycles
Tuesday, 23 March 2004
NEW YORK (Reuters Health) - The addition of the drug aprepitant to other antiemetic therapy is associated with less nausea and vomiting during an initial cycle of chemotherapy, and the response is maintained well during subsequent cycles, investigators report.
read more
|
Alternative Therapies Popular with Cancer Patients
Tuesday, 24 February 2004
NEW YORK (Reuters Health) - Insured cancer patients in the State of Washington are considerably more likely to use complementary and alternative medical providers than are insured patients without the disease, researchers report in the February 23rd online edition of Cancer.
read more
|
Cancer Web Sites No Aid to Trial Enrollment
Tuesday, 10 February 2004
NEW YORK (Reuters Health) - Web sites for organizations involved in clinical cancer research lack sufficient information to enhance patient enrollment in clinical trials, according to a report in the February 9th online edition of Cancer.
read more
|
Survival Improved in Penile Carcinoma Patients Undergoing Early Inguinal Lymphadenectomy as Opposed to Surveillance
Monday, 02 February 2004
BERKELEY, CA (UroToday Inc.) - Improved guidelines for treating patients with penile carcinoma by inguinal lymphadenectomy evolved over the past 20 years.
read more
|
T Cell Priming Quells Tumors in Mice
Monday, 05 January 2004
NEW YORK (Reuters Health) - Priming of naive T cells inside established murine tumors via a member of the tumor necrosis family, LIGHT (also known as TNSF-14), leads to tumor eradication, researchers report. The approach might "be used to treat local tumors that cannot be surgically removed and to treat metastatic tumors after the primary tumor is surgically removed."
read more
|
Urothelial Cancer Often Recurs After Transitional Cell Carcinoma
Wednesday, 05 November 2003
NEW YORK (Reuters Health) - Patients with primary upper urinary tract transitional cell carcinoma (UUT-TCC) are at increased risk for recurrent bladder cancer and therefore need regular cystoscopic follow up, investigators from Taiwan report in the October 15th issue of the journal Cancer.
read more
|
Penis & Urethra Cancer 
